140D042690013
Other Transaction Agreement
Overview
Government Description
Evidence-driven Manufacturing To Expand Pediatric Cell Therapy Access in Rare Diseases
Awarding Agency
Funding Agency
NAICS
Not Reported
Place of Performance
Los Angeles, CA 90033 United States
Pricing
Other
Set Aside
None
Extent Competed
Competed
Related Opportunity
None
University Of Southern California was awarded
Other Transaction Agreement 140D042690013 140D042690013
for Evidence-Driven Pediatric Cell Therapy Expansion
worth up to $6,842,620
by the National Institutes of Health
in February 2026.
The contract
has a duration of 2 years 1 months and
was awarded
full & open
with
PSC AN13
via program solicitation acquisition procedures.
Status
(Open)
Last Modified 3/3/26
Period of Performance
2/27/26
Start Date
3/31/28
Current End Date
3/31/28
Potential End Date
Obligations
$6.8M
Total Obligated
$6.8M
Current Award
$6.8M
Potential Award
Award Hierarchy
Other Transaction Agreement
140D042690013
Subcontracts
OTA Details
Type of Agreement
Prototype
Non-Governmental Funding
None Reported
Non-Traditional Participation
Non-Traditional Significant Participation
Activity Timeline
People
Suggested agency contacts for 140D042690013
Competition
Number of Bidders
Not Applicable
Solicitation Procedures
Program Solicitation
Evaluated Preference
None
Commercial Item Acquisition
None
Simplified Procedures for Commercial Items
None
Other Categorizations
Subcontracting Plan
Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
G88KLJR3KYT5
Awardee CAGE
1B729
Agency Detail
Awarding Office
140D04 IBC ACQ SVCS DIRECTORATE (00004)
Funding Office
75N992
Created By
decarloj
Last Modified By
decarloj
Approved By
decarloj
Legislative
Legislative Mandates
None Applicable
Performance District
CA-34
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Representative
Jimmy Gomez
Modified: 3/3/26